BURRELL INTERNATIONAL GROUP LLC

Lobbying for TONIX PHARMACEUTICALS HOLDING CORP. · Pharmaceutical Company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $40,000.00 income · posted Oct 18, 2025

Lobbying activity 1

Pharmacy

LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY26 Defense Appropriation for broad-spectrum antivirals, FY26 LHHS for Long COVID and cocaine overdose funding; Alternative to Pain Act and Chronic Pain coverage

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.